Molecular screening for hereditary nonpolyposis colorectal cancer in Bulgaria

• Authors: Tanya Kadiyska , Teodora Goranova , Ganka Dineva , Dimitar Nedin , Alexandrina Alexandrova , Antonina Gegova , Radka Kaneva , Damyan Damyanov , Ivo Kremensky , Vanio Mitev
• Languages of publication: EN

Abstracts

EN

Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disease, caused by germline mutations in DNA mismatch-repair genes (MMR). These mutations lead to microsatellite instability (MSI). It has been found that the MSI is not confined to the setting of hereditary disease and may be seen in approximately 12-17% of the sporadic CRCs. In 1998 a National Registry for CRC was instituted in Queen Giovanna Hospital, Sofia. A total of 150 patients have been selected for MSI analysis and 25 tumors showed to be unstable, 14 with loss of heterozygosity (LOH). These tumors were further analyzed for MLH1 promoter hypermethylation and a significant association between this epigenetic change and MSI/LOH sporadic cases. We proposed this method as a step that follows the analysis for MSI and prior to the screening for MMR mutations. The mutation screening detected four known and two novel mutations, one unpublished and four known intronic polymorphisms in both hMLH1 and hMSH2 genes. The use of IHC analysis has been found effective in the investigation of some unclear molecular variations.We developed an efficient diagnostic strategy for HNPCC testing and the mutation status of 80% MSI HNPCC cases could be detected.

Keywords

EN

HNPCC; immunohistochemistry; hMLH1; hMSH2; MSI

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2006
• Volume: 1
• Issue: 2
• Pages: 128-135

Dates

published

1 - 6 - 2006

online

1 - 6 - 2006

Contributors

author

Tanya Kadiyska

• Laboratory of Molecular Pathology, University Hospital of Obstetrics and Gynaecology “Maichin Dom”, Sofia, 1431, Bulgaria

author

Teodora Goranova

• Laboratory of Molecular Pathology, University Hospital of Obstetrics and Gynaecology “Maichin Dom”, Sofia, 1431, Bulgaria

author

Ganka Dineva

• Laboratory of Molecular Pathology, University Hospital of Obstetrics and Gynaecology “Maichin Dom”, Sofia, 1431, Bulgaria

author

Dimitar Nedin

• Clinic of Abdominal Surgery, Queen Giovanna Hospital, Sofia, 1526, Bulgaria

author

Alexandrina Alexandrova

• Clinic of Abdominal Surgery, Queen Giovanna Hospital, Sofia, 1526, Bulgaria

author

Antonina Gegova

• Clinic of Abdominal Surgery, Queen Giovanna Hospital, Sofia, 1526, Bulgaria

author

Radka Kaneva

• Laboratory of Molecular Pathology, University Hospital of Obstetrics and Gynaecology “Maichin Dom”, Sofia, 1431, Bulgaria

author

Damyan Damyanov

• Clinic of Abdominal Surgery, Queen Giovanna Hospital, Sofia, 1526, Bulgaria

author

Ivo Kremensky

• Laboratory of Molecular Pathology, University Hospital of Obstetrics and Gynaecology “Maichin Dom”, Sofia, 1431, Bulgaria

author

Vanio Mitev

• Department of Chemistry and Biochemistry, Medical University, Sofia, 1431, Bulgaria

References

• [1] A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, A. Ghafoor, E.J. Feuer and M.J. Thun: “Cancer statistics, 2005”, CA Cancer J. Clin., Vol. 55(1), (2005), pp. 10–30. http://dx.doi.org/10.3322/canjclin.55.1.10[Crossref]
• [2] H.T. Lynch and A. de la Chapelle: “Genetic susceptibility to non-polyposis colorectal cancer”, J. Med. Genet., Vol. 36, (1999), pp. 801–818.
• [3] P. Peltomaki and H.F. Vasen: “Mutations predisposing to hereditary nonpolyposis colorectal cancer, database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer”, Gastroenterology, Vol. 113, (1997), pp. 146–158. http://dx.doi.org/10.1053/gast.1997.v113.pm9322509[Crossref]
• [4] Y. Ionov, M.A. Peinado, S. Malkhosyan, D. Shibata and M. Perucho: “Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis”, Nature, Vol. 363, (1993), pp. 558–561. http://dx.doi.org/10.1038/363558a0[Crossref]
• [5] P.A. Jones and P.W. Laird: “Cancer epigenetics comes of age”, Nat. Genet., Vol. 21(2), (1999), pp. 163–167. http://dx.doi.org/10.1038/5947[Crossref]
• [6] T. Kadiyska, M. Tzancheva, D. Nedin, A. Alexandrova, M. Marinov, R. Kaneva, D. Damyanov, V. Mitev and I. Kremensky: “MLH1 promoter hypermethylation in bulgarian patients with colorectal cancer”, BJMG, Vol. 6, (2003), pp. 3–8.
• [7] C.R. Boland, S.N. Thibodeau, S.R. Hamilton, D. Sidransky, J.R. Eshleman, R.W. Burt, et al.: “A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer”, Cancer Res., Vol. 58, (1998), pp. 5248–5257.
• [8] H. Hampel, W.L. Frankel, E. Martin, M. Arnold, K. Khanduja, P. Kuebler, H. Nakagawa, K. Sotamaa, T.W. Prior, J. Westman, J. Panescu, D. Fix, J. Lockman, I. Comeras and A. de la Chapelle: “Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)”, N. Engl. J. Med., Vol. 352(18), (2005), pp. 1851–1860. http://dx.doi.org/10.1056/NEJMoa043146[Crossref]
• [9] A. Percesepe, F. Borghi, M. Menigatti, L. Losi, M. Foroni, C. Di Gregorio, G. Rossi, M. Pedroni, E. Sala, F. Vaccina, L. Roncucci, P. Benatti, A. Viel, M. Genuardi, G. Marra, P. Kristo, P. Peltomaki and M. Ponz de Leon: “Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study”, J. Clin. Oncol., Vol. 19(19), (2001), pp. 3944–3950.
• [10] R.A. Lothe, P. Peltomaki, G.I. Meling, L.A. Aaltonen, M. Nystrom-Lahti, L. Pylkkanen, K. Heimdal, T.I. Andersen, P. Moller and T.O. Rognum: “Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history”, Cancer Res., Vol. 53(24), (1993), pp. 5849–5852.
• [11] S.N. Thibodeau, A.J. French, J.M. Cunningham, D. Tester, L.J. Burgart, P.C. Roche, S.K. McDonnell, D.J. Schaid, C.W. Vockley, V.V. Michels, G.H. Farr and M.J. O’Connell: “Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1”, Cancer Res., Vol. 58, (1998), pp. 1713–1718.
• [12] Y.M. Song and S. Zheng: “Analysis for phenotype of HNPCC in China”, World J. Gastroenterol., Vol. 8(5), (2002), pp. 837–840.
• [13] J.G. Herman, A. Umar, K. Polyak, J.R. Graff, N. Ahuja, J.P. Issa, S. Markowitz, J.K. Willson, S.R. Hamilton, K.W. Kinzler, M.F. Kane, R.D. Kolodner, B. Vogelstein, T.A. Kunkel and S.B. Baylin: “Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma”, Proc. Natl. Acad. Sci. USA, Vol. 95(12), (1998), pp. 6870–6875. http://dx.doi.org/10.1073/pnas.95.12.6870[Crossref]
• [14] J.M. Cunningham, E.R. Christensen, D.J. Tester, C.Y. Kim, P.C. Roche, L.J. Burgart and S.N. Thibodeau: “Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability”, Cancer Res., Vol. 58(15), (1998), pp. 3455–3460.
• [15] M.L. Veigl, L. Kasturi, J. Olechnowicz, A.H. Ma, J.D. Lutterbaugh, S. Periyasamy, G.M. Li, J. Drummond, P.L. Modrich, W.D. Sedwick and S.D. Markowitz: “Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers”, Proc. Natl. Acad. Sci. USA, Vol. 95(15), (1998), pp. 8698–8702. http://dx.doi.org/10.1073/pnas.95.15.8698[Crossref]
• [16] S. Ramchandani, A.R. MacLeod, M. Pinard, E. von Hofe, M. Szyf: “Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide”, Proc. Natl. Acad. Sci. USA, Vol. 94(2), (1997), pp. 684–689. http://dx.doi.org/10.1073/pnas.94.2.684[Crossref]
• [17] K. Drotschmann, A.B. Clark, H.T. Tran, M.A. Resnick, D.A. Gordenin and T.A. Kunkel: “Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene”, Proc. Natl. Acad. Sci. USA, Vol. 96(6), (1999), pp. 2970–2975. http://dx.doi.org/10.1073/pnas.96.6.2970[Crossref]

Identifiers

DOI

10.2478/s11536-006-0013-z